Gout Presentation

17
GOUT

Transcript of Gout Presentation

Page 1: Gout Presentation

GOUT

Page 2: Gout Presentation

What is Gout?

• Crystal arthritis• Deposition of uric acid crystals in joints• Presents with acute monoarticular arthritis in 90 %

of patients.• Men > Women • Onset 40-60 years• Very treatable• Untreated, may lead to chronic tophaceous gout.

Page 3: Gout Presentation

History

• Pain, swelling and redness of affected joint• Pain exacerbated by movement• May be pyrexial• Podagra is initial presentation in 50 %

cases.• Starts abruptly, max intensity within 8-12

hours.• Resolves spontaneously < 2 weeks

Page 4: Gout Presentation

Uric Acid Metabolism

Nucleic Acids

Hypoxanthine

Xanthine

Uric Acid

Xanthine Oxidase

Xanthine Oxidase

Excretion by Kidney

Page 5: Gout Presentation

What goes wrong?

Nucleic Acids

Hypoxanthine

Xanthine

Uric Acid

Xanthine Oxidase

Xanthine Oxidase

Excretion by Kidney

GOUT

Impaired renal excretion

Increased nucleic acids

Page 6: Gout Presentation

Predisposing Factors• Gender- male > female• Family History• Previous attack• Body size - large > small• Alcohol• Diet – purine rich• Diuretics• Causes of high cell turnover e.g. psoriasis, chemotherapy• Renal insufficiency

Page 7: Gout Presentation

What happens in the joint?

• Supersaturation leads to urate crystal deposition within joint.

• Leads to inflammatory response Symptoms

Page 8: Gout Presentation

Investigations• Joint aspiration - polarising light

microscopy for crystals• FBC - white cells raised• ESR - raised• X-ray - generally normal • Serum urate

HIGH SERUM URATE DOES NOT NECESSARILY MEAN THE PATIENT HAS GOUT!

Page 9: Gout Presentation

Treatment of Acute Attack

• NSAID • Colchicine

– GI side effects, – Most effective in 1st 24 hours

• Corticosteroid– If NSAID and colchicine contraindicated

AIM- to reduce symptoms

Page 10: Gout Presentation

Prevention of Further Attacks

• Lifestyle changes – to minimise risk factors• Drug therapies

– Xanthine oxidase inhibitors e.g. Allopurinol– Uricosuric agents e.g. Probenecid

• Need to be taken for life• Can precipitate an acute attack therefore

give together with NSAID or colchicine for 2 months.

AIM - Prophylaxis

Page 11: Gout Presentation

Site of drug action

Nucleic Acids

Hypoxanthine

Xanthine

Uric Acid

Xanthine Oxidase

Xanthine Oxidase

Excretion by KidneyUricosuric agents

e.g. Probenecid

XO inhibitors e.g. Allopurinol

GOUT

Page 12: Gout Presentation

Chronic Tophaceous Gout

• If gout untreated• Other joint involvement • Formation of tophi- collection of crystals in

soft tissues• Bone erosion at joints- ‘punched out’

erosions on x-ray.

Page 13: Gout Presentation

Tophi

Page 14: Gout Presentation

X-rays

Page 15: Gout Presentation

Key Points• Gout is due to deposition of urate crystals in joints

leading to inflammation.• Diagnosis is by history and polaroid microscopy of

synovial fluid.• High serum uric acid does NOT mean the patient

has gout.• Gout is one of the most treatable arthritic

conditions.• Treat acute attack and then consider prophylaxis of

future episodes.• If untreated, can develop into chronic tophaceous

gout.

Page 16: Gout Presentation

Summary

• Many predisposing/risk factors• Typical history• Investigations• Treatment - understanding of uric acid

metabolism• Chronic tophaceous gout

Page 17: Gout Presentation

References• Francis M, 2006. eMedicine - Gout.

http://www.emedicine.com/med/topic924.htm. Accessed 10/2/2007• Andrew J, Herrick A and Marsh D. Musculoskeletal Medicine and

Surgery. Churchill Livingstone, London 2000.• Underwood J. General and Systemic Pathology Third Edition.

Churchill Livingstone, 2003